The healthcare sector climbed 1.11% at midday Tuesday.

Stocks rallied after some volatility on Wall Street, with investors cautiously optimistic after a temporary pause on tariffs on some electronic devices. The S&P 500 closed up 2.2%.

Botanix Pharmaceuticals (ASX:BOT) received firm commitments to raise AU$40 million via a non-underwritten institutional placement, its shares rose 9% in midday trade.

On the flip side, the information technology stocks fell, shedding 0.45%.

EROAD (ASX:ERD, NZE:ERD) does not expect any material impact of the US' 10% blanket tariffs on its revenue or earnings, generating 44% of its revenue from the US market, with roughly 88% being from services not subject to the US import tariffs. It produces most of its hardware products through manufacturers in Indonesia, the Philippines, and Vietnam.